AAQ1 aap Implantate AG
aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides cannulated screws, as well as offers antibacterial silver coating technology and our magnesium-based implants. The company sells its products directly to hospitals, purchasing groups, and hospital groups through a network of distributors. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.…
Industry Peers
Medical DevicesKey Statistics
About aap Implantate (ETR: AAQ1)
›
aap Implantate (ETR: AAQ1) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 105 employees.
The shares were at 1.430 EUR on 19 November 2026, up 0.7% over 52 weeks. Its 52-week range is 1.260 EUR to 2.220 EUR: the price is 35.6% below the high and 13.5% above the low.
Its market capitalisation is 21.18M EUR.
aap Implantate reports return on equity of -29.7%, an operating margin of -22.7% and revenue down 4.5% year over year.
Its debt exceeds its cash by 3.69M EUR, a debt-to-equity ratio of 0.11. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.